Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,237 | -49,808 | -35,964 | -18,821 | -53,020 |
| Depreciation Amortization | 16,195 | 12,115 | 8,027 | 4,049 | 18,486 |
| Accounts receivable | 6,729 | 11,438 | 9,419 | 9,843 | -7,628 |
| Accounts payable and accrued liabilities | 1,281 | 1,412 | 1,903 | 3,363 | 3,356 |
| Other Working Capital | -19,933 | -13,040 | -8,622 | -2,284 | 2,414 |
| Other Operating Activity | 10,904 | 824 | -2,328 | -9,051 | 20,975 |
| Operating Cash Flow | $-44,061 | $-37,059 | $-27,565 | $-12,901 | $-15,417 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13,264 | -12,801 | -11,095 | -6,923 | -12,717 |
| Net Acquisitions | 1,318 | 2,000 | 2,000 | 2,000 | 15,882 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 36,810 |
| Investing Cash Flow | $-11,946 | $-10,801 | $-9,095 | $-4,923 | $39,975 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 16,838 | 10,000 | N/A | N/A | N/A |
| Debt Repayment | -501 | -501 | -501 | -501 | N/A |
| Common Stock Issued | 1,494 | 893 | 894 | N/A | 22,000 |
| Other Financing Activity | -1,872 | -1,730 | -1,552 | -525 | -1,143 |
| Financing Cash Flow | $15,959 | $8,662 | $-1,159 | $-1,026 | $20,857 |
| Exchange Rate Effect | -21 | -13 | 162 | 74 | 385 |
| Beginning Cash Position | 69,536 | 69,536 | 69,536 | 69,536 | 23,736 |
| End Cash Position | 29,467 | 30,325 | 31,879 | 50,760 | 69,536 |
| Net Cash Flow | $-40,069 | $-39,211 | $-37,657 | $-18,776 | $45,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,061 | -37,059 | -27,565 | -12,901 | -15,417 |
| Capital Expenditure | -13,264 | -12,801 | -11,095 | -6,923 | -12,717 |
| Free Cash Flow | -57,325 | -49,860 | -38,660 | -19,824 | -28,134 |